摘要
Aberrant inhibition of B-cell receptor (BCR)-induced programmed cell death pathways is frequently associated with the development of human auto-reactive B-cell lymphomas. Here, we integrated loss-of-function, genomic, and bioinformatics approaches for the identification of oncogenic mechanisms linked to the inhibition of BCR-induced clonal deletion pathways in human B-cell lymphomas. Lentiviral (HIV)-based RNA interference screen identified MCL1 as a key survival molecule linked to BCR signaling. Loss of MCL1 by RNA interference rendered human B-cell lymphomas sensitive to BCR-induced programmed cell death. Conversely, MCL1 overexpression blocked programmed cell death on BCR stimulation. To get insight into the mechanisms of MCL1 -induced survival and transformation, we screened 41 000 human genes in a genome-wide gene expression profile analysis of MCL1-overexpressing B-cell lymphomas. Bioinformatic gene network reconstruction illustrated reprogramming of relevant oncoproteins within beta-catenin-T-cell factor signaling pathways induced by enforced MCL1 expression. Overall, our findings not only illustrate MCL1 as an aberrantly expressed reprogramming oncoprotein in follicular lymphomas but also highlight MCL1 as key therapeutic target.
学科与关键词
- Myeloid cell leukemin-1 inhibitors: a growing arsenal for cancer therapyPeng-Ju Zhu; Ze-Zhou Yu; Qi-Dong You; Zheng-Yu JiangDrug Discovery Today, 2020, 25(10): 1873-1882.
- High-Expressed CXCR7 Contributes to CXCL12-Mediated Protection from Apoptosis in Lymphoma CellsDongsheng, Xu; Xiaobei, DengJournal of Molecular and Genetic Medicine, 2016, 10(2).
- Novel Pharmacotherapies for B-Cell Lymphomas and LeukemiasMichael T , Tees; Lubomir, SokolAMERICAN JOURNAL OF THERAPEUTICS, 2016, 23(2): e498-e520.
